Search company, investor...

Compare 20/20 GeneSystems vs RainDance Technologies

Customers evaluate the quality of 20/20 GeneSystems's products using the following success metrics.

Overview

20/20 GeneSystems is based in United States

20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a proprietary algorithm to combine the biomarker values to generate a unitary risk score.

RainDance Technologies is 20 yrs old and is based in United States.

RainDance Technologies is a life sciences company developing products that enable more accurate, reliable, cost-effective and early detection of disease and predisposition risk in order to improve human healthcare. The company is focused on better healthcare outcomes and lowering costs for the research, diagnosis, and treatment of cancers and inherited diseases. The company's RainStorm digital droplet technology powers next-generation sequencing and genetic testing systems that deliver superior performance, cost, interpretability, and ease of use. RainDance systems are used routinely in major academic research institutions, clinical genetics laboratories, and hospitals around the world. Based in Lexington, Massachusetts, the company supports customers through its international sales and service operations as well as a global network of distributors and commercial service providers. On January 16th, 2017, RainDance Technologies was acquired by Bio Rad. The terms of the transaction were not disclosed.

Country

United States

Demo Video

Demo not available because 20/20 GeneSystems has not claimed their profile.

Work for 20/20 GeneSystems? Show off your product.

Demo not available because RainDance Technologies has not claimed their profile.

Work for RainDance Technologies? Show off your product.

Leadership

Jonathan Cohen (Founder, Chief Executive Officer, President)

See all 3 people

Kathy Ordonez (Chief Executive Officer)

See all 5 people

Total Raised

Investors

Keiretsu Forum, Ping An Venture Capital

See all 5 investors

Bio-Rad Laboratories, Alloy Ventures

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because 20/20 GeneSystems has not claimed their profile.

Work for 20/20 GeneSystems? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for 20/20 GeneSystems?

Claim your profile now.

Information not available because RainDance Technologies has not claimed their profile.

Work for RainDance Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for RainDance Technologies?

Claim your profile now.

Expert Collections

D

Digital Health

10,553 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

O

Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.